Phase 3 × Has results × Leukemia × Clear all
NCT00651261 2021-08-18

Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Alliance for Clinical Trials in Oncology

Phase 3 Unknown
717 enrolled 14 charts
NCT02130557 2021-05-18

A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Pfizer

Phase 3 Completed
536 enrolled 24 charts 1 FDA
NCT00516503 2017-08-24

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
208 enrolled 12 charts
NCT00755040 2017-03-07

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
164 enrolled 8 charts
NCT00719563 2017-02-09

American Ginseng in Treating Patients With Fatigue Caused by Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
364 enrolled 29 charts
NCT00666211 2012-09-06

Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
98 enrolled 14 charts
NCT00661999 2011-05-17

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

Mayo Clinic

Phase 3 Completed
502 enrolled 30 charts